Contact us

News & Press

Tulavi and VHSS Partner to Bring Groundbreaking Surgical Nerve Treatment to Veterans Impacted by Amputations and Traumatic Injuries

July 23, 2025

LOS GATOS, Calif., July 23, 2025 /PRNewswire/ — Tulavi Therapeutics, a private medical technology company focused on advancing surgical solutions that address critical unmet needs in peripheral nerve surgery and repair, today announced a new partnership with Veterans Healthcare Supply Solutions (VHSS) to distribute the allay™ Hydrogel Cap to U.S. Department of Veterans Affairs (VA) hospitals and Military Treatment Facilities nationwide. This milestone brings Tulavi’s innovative technology to the forefront of veteran care and expands access to a new treatment for peripheral nerve injuries while broadening the scope of advanced surgical options for nerve protection and recovery. More than 60,000 U.S. veterans are living with limb loss, and countless others have sustained traumatic peripheral nerve injuries requiring surgical intervention. In these

Read More >

Tulavi Therapeutics Appoints Raymond W. Cohen as Vice Chairman of its Board of Directors

June 18, 2025

Veteran medtech executive brings proven track record of scaling innovative medical device companies and successful exits LOS GATOS, Calif., June 18, 2025 /PRNewswire/ — Tulavi Therapeutics, Inc. (“Tulavi”), a medical device company transforming peripheral nerve surgery with its Adaptive Hydrogel Technology, today announced the appointment of Raymond W. Cohen to serve as Vice Chairman of its Board of Directors. “We are thrilled to welcome Ray to our Board of Directors at this pivotal moment in Tulavi’s growth trajectory,” said Josh Vose MD, CEO of Tulavi Therapeutics. “Ray brings to our board an exceptional track record of building and scaling innovative medical device companies, combined with his deep understanding of hydrogels, neurology, and device markets.

Read More >